Scinai Immunotherapeutics (SCNI) Operating Income Growth (5y) (2019 - 2026)
Scinai Immunotherapeutics (SCNI) Operating Income Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.60 Bn | 466.80 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.71 Bn | 114.46 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.83 Bn | 61.07 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn |
| 10 | Scinai Immunotherapeutics | 3.74 Bn | 627.11 Mn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.02% |
| Mar 31, 2025 | 39.93% |
| Sep 30, 2024 | 33.72% |
| Jun 30, 2024 | -74.27% |
| Mar 31, 2024 | 17.81% |
| Dec 31, 2023 | 50.85% |
| Sep 30, 2023 | -4.58% |
| Jun 30, 2023 | 18.27% |
| Mar 31, 2023 | 23.62% |
| Dec 31, 2022 | 6.08% |
| Mar 31, 2022 | -26.20% |
| Mar 31, 2021 | -21.89% |
| Dec 31, 2020 | -31.73% |
| Sep 30, 2020 | 93.50% |
| Mar 31, 2020 | -61.55% |
| Sep 30, 2019 | -57.38% |
| Mar 31, 2019 | -28.82% |